ArticleClinical drug investigation2017

Exposure-Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies.

Chih-Wei Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.